<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We previously reported <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of <z:chebi fb="0" ids="16856">glutathione</z:chebi> S-transferases theta (GSTT)-1, <z:mp ids='MP_0002169'>wild type</z:mp> (623 bp) and mutant (500 bp), in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>The deletion of 123 bp creates a sequence that is homologous to the mammalian target of <z:chebi fb="0" ids="9168">rapamycin</z:chebi> (mTOR) </plain></SENT>
<SENT sid="2" pm="."><plain>To analyze the function of mutant GSTT-1 gene, stable transformants for the mutant and <z:mp ids='MP_0002169'>wild-type</z:mp> GSTT-1 gene, respectively, were established </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, the expression of the wild and mutant type of the GSTT-1 gene of those stable transformants in cell lines and in bone marrow cells from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients by reverse-transcription polymerase chain reaction (RT-PCR) was observed in the presence or absence of <z:chebi fb="0" ids="9168">rapamycin</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Significant growth inhibition by <z:chebi fb="0" ids="9168">rapamycin</z:chebi> was observed among stable transformants for the mutant GSTT-1 gene, but not <z:mp ids='MP_0002169'>wild type</z:mp> GSTT-1 gene, and was indicative of typical <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
</text></document>